|
|
|
|
|
|
Sponsors and Collaborators: |
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute National Cancer Institute (NCI) |
Information provided by: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT00526526 |
RATIONALE: Yoga may improve inflammation, fatigue, and depression in postmenopausal breast cancer survivors.
PURPOSE: This randomized clinical trial is studying how well Hatha yoga works in improving physical activity, inflammation, fatigue, and distress in postmenopausal breast cancer survivors.
Condition | Intervention |
Breast Cancer Depression Fatigue Pain |
Procedure: chromatography Procedure: fatigue assessment and management Procedure: flow cytometry Procedure: immunoenzyme technique Procedure: management of therapy complications Procedure: observation Procedure: psychosocial assessment and care Procedure: quality-of-life assessment Procedure: yoga therapy |
Genetics Home Reference related topics: | breast cancer |
MedlinePlus related topics: | Breast Cancer Cancer Depression |
Study Type: | Interventional |
Study Design: | Supportive Care, Randomized, Double-Blind, Active Control |
Official Title: | Breast Cancer Survivors: Physical Activity, Inflammation, Fatigue, and Distress |
Estimated Enrollment: | 250 |
Study Start Date: | August 2007 |
Estimated Primary Completion Date: | August 2013 (Final data collection date for primary outcome measure) |
OBJECTIVES:
Primary
Secondary
OUTLINE: This is a multicenter study. Patients are stratified according to stage of cancer (stage I vs stage II and stage IIIA) and prior radiation therapy (yes vs no). Patients are randomized to 1 of 2 intervention arms.
In both arms, patients are physically assessed, interviewed, and then complete heath and health-related behavior questionnaires regarding psychological (quality of life, perceived stress, and stress responsiveness), behavioral (health behaviors), physical functioning (physical symptoms, pain, flexibility, and functional status), and physiological stress responses (NF-κB and proinflammatory cytokine responses to a laboratory stressor) at baseline, 3 months, and 6 months.
Patients undergo fasting blood sample collection at baseline, 3 months, and 6 months to analyze fatty acid composition of plasma by gas chromatography, changes in immune function, proinflammatory cytokine, and key inflammation markers of fatigue and stress by ELISA, flow cytometry, and indirect immunofluorescence (IF) test. Additionally, patient response to laboratory stressors are assessed at baseline using the Trier Social Stress Test (TSST). Saliva samples are collected periodically and before and after the TSST for cortisol level measurement.
Ages Eligible for Study: | 21 Years and older |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Completed cancer treatment within the past 24 months (except for tamoxifen/aromatase inhibitors)
Women who are not currently practicing yoga and have not participated in any of the following activities:
PATIENT CHARACTERISTICS:
Inclusion criteria:
Exclusion criteria:
Diagnosis of any of the following conditions:
PRIOR CONCURRENT THERAPY:
United States, Ohio | |||||
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center | Recruiting | ||||
Columbus, Ohio, United States, 43210-1240 | |||||
Contact: Clinical Trials Office - OSU Comprehensive Cancer Center 614-293-4976 osu@emergingmed.com |
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute |
National Cancer Institute (NCI) |
Study Chair: | Janice Kiecolt-Glaser, PhD | Arthur G. James Cancer Hospital & Richard J. Solove Research Institute |
Clinical trial summary from the National Cancer Institute's PDQ® database 
  |
Study ID Numbers: | CDR0000562452, OSU-2007C0004, OSU-06137 |
First Received: | September 5, 2007 |
Last Updated: | July 23, 2008 |
ClinicalTrials.gov Identifier: | NCT00526526 |
Health Authority: | Unspecified |
|
|
|
|
|